Sam Isaly is the Founder and the Managing Partner of OrbiMed Advisors and Exome Asset Management. He is one of the world’s most eminent healthcare fund managers and has been active in global healthcare investing and analysis since 1968. Over the course of his career, Isaly served as a pharmaceutical analyst with Chase Manhattan Bank, Merrill Lynch, Legg Mason, and S.G. Warburg.